PVP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
PVP Ventures Ltd has signed binding agreements to acquire a 56% stake in Optimus Oncology Pvt. Ltd. (OOPL) for an initial investment of about INR 55 Crores, with a plan to raise the stake to 76% over the coming years based on milestones. OOPL, founded in 2018 by Tata Memorial Hospital-trained radiation oncologists, runs cancer treatment centres in partner hospitals across Tier 2 and Tier 3 towns in Maharashtra (Dhule, Latur, Akola, Solapur) and plans to expand into Gujarat and Madhya Pradesh. The company currently has EBITDA of over INR 10 Crores and aims to reach INR 50 Crores in the next 5 years. PVP is funding this from expected realty cash flows of over INR 2,000 Crores over the next 6 years, as it builds a technology-led healthcare services platform.
This is a strategic diversification move into healthcare for PVP Ventures, shifting from its realty legacy toward a scalable oncology platform addressing a clear gap in smaller Indian cities. For shareholders, it signals a new growth vertical but execution and milestone-based future investments carry risk; near-term stock impact may depend on how the market views the INR 55 Crore deployment versus the projected INR 50 Crore EBITDA target.